Literature DB >> 19243052

Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.

Lucia Martiniova1, Melanie S Kotys, David Thomasson, Daniel Schimel, Edwin W Lai, Marcelino Bernardo, Maria J Merino, James F Powers, Jan Ruzicka, Richard Kvetnansky, Peter L Choyke, Karel Pacak.   

Abstract

PURPOSE: To compare contrast-enhanced micro-computed tomography (microCT) and nonenhanced respiratory-triggered magnetic resonance imaging (MRI) in an animal model of metastatic pheochromocytoma. Animal models are becoming important in the study of cancer treatment and imaging is useful in minimizing the number of animals needed and reducing costs associated with autopsies. However, the choice of imaging modality is still evolving.
MATERIALS AND METHODS: Adult female nude mice were injected by tail vein with a mouse pheochromocytoma (MPC) cell line (MPC 4/30PRR) to create a metastatic model. After optimizing imaging techniques, eight mice were imaged with both respiratory triggered MRI and microCT and the findings were verified histologically.
RESULTS: MicroCT and MRI were approximately equal in their ability to detect hepatic metastases at a size threshold of 350 microm. In the lungs, MRI was more sensitive than microCT, detecting lesions 0.6 mm in diameter versus 1 mm for microCT. Additionally, MRI was more sensitive for lesions in the kidneys, bone, ovaries, and adrenal glands. MRI demonstrated a higher contrast-to-noise ratio (CNR) than microCT.
CONCLUSION: In addition to the advantage of not exposing the animal to ionizing radiation, MRI provided a more complete assessment of the extent of metastases in this model compared to microCT. Copyright (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243052      PMCID: PMC2750094          DOI: 10.1002/jmri.21654

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  21 in total

1.  Hepatobiliary imaging using a novel hepatocyte-selective CT contrast agent.

Authors:  Douglas A Bakan; Fred T Lee; Jamey P Weichert; Marc A Longino; Raymond E Counsell
Journal:  Acad Radiol       Date:  2002-05       Impact factor: 3.173

2.  Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography.

Authors:  D A Bakan; M A Longino; J P Weichert; R E Counsell
Journal:  J Pharm Sci       Date:  1996-09       Impact factor: 3.534

3.  Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features.

Authors:  R I Linnoila; H R Keiser; S M Steinberg; E E Lack
Journal:  Hum Pathol       Date:  1990-11       Impact factor: 3.466

4.  Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits.

Authors:  J P Weichert; F T Lee; S G Chosy; M A Longino; J E Kuhlman; D M Heisey; G E Leverson
Journal:  Radiology       Date:  2000-09       Impact factor: 11.105

5.  Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.

Authors:  G Eisenhofer; M M Walther; T T Huynh; S T Li; S R Bornstein; A Vortmeyer; M Mannelli; D S Goldstein; W M Linehan; J W Lenders; K Pacak
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

6.  Tyrosinase: a developmentally specific major determinant of peripheral dopamine.

Authors:  Graeme Eisenhofer; Hua Tian; Courtney Holmes; Jun Matsunaga; Suzanne Roffler-Tarlov; Vincent J Hearing
Journal:  FASEB J       Date:  2003-07       Impact factor: 5.191

Review 7.  Functional imaging of endocrine tumors: role of positron emission tomography.

Authors:  Karel Pacak; Graeme Eisenhofer; David S Goldstein
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

8.  Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement.

Authors:  Sharon M Weber; Karen A Peterson; Benjamin Durkee; Chen Qi; Mark Longino; Thomas Warner; Fred T Lee; Jamey P Weichert
Journal:  J Surg Res       Date:  2004-06-01       Impact factor: 2.192

9.  Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine.

Authors:  G Eisenhofer; A Aneman; D Hooper; C Holmes; D S Goldstein; P Friberg
Journal:  Am J Physiol       Date:  1995-04

10.  Polyiodinated triglyceride analogs as potential computed tomography imaging agents for the liver.

Authors:  J P Weichert; M A Longino; D A Bakan; M G Spigarelli; T S Chou; S W Schwendner; R E Counsell
Journal:  J Med Chem       Date:  1995-02-17       Impact factor: 7.446

View more
  19 in total

1.  Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.

Authors:  Lucia Martiniova; Shiromi M Perera; Frederieke M Brouwers; Salvatore Alesci; Mones Abu-Asab; Amanda F Marvelle; Dale O Kiesewetter; David Thomasson; John C Morris; Richard Kvetnansky; Arthur S Tischler; James C Reynolds; Antonio Tito Fojo; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2011-01-13       Impact factor: 5.678

2.  Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

Authors:  Lucia Martiniova; Susannah Cleary; Edwin W Lai; Dale O Kiesewetter; Jurgen Seidel; Linda F Dawson; Jacqueline K Phillips; David Thomasson; Xiaoyuan Chen; Graeme Eisenhofer; James F Powers; Richard Kvetnansky; Karel Pacak
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

3.  Quantitative analysis of tumor burden in mouse lung via MRI.

Authors:  Vanessa K Tidwell; Joel R Garbow; Alexander S Krupnick; John A Engelbach; Arye Nehorai
Journal:  Magn Reson Med       Date:  2011-09-27       Impact factor: 4.668

Review 4.  Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Buffet; Aurélie Morin; Judith Goncalves; Judith Favier
Journal:  Cell Tissue Res       Date:  2018-02-09       Impact factor: 5.249

5.  Highly metastatic K7M2 cell line: A novel murine model capable of in vivo imaging via luciferase vector transfection.

Authors:  Brian T Grisez; Justin J Ray; Phillip A Bostian; Justin E Markel; Brock A Lindsey
Journal:  J Orthop Res       Date:  2018-02-10       Impact factor: 3.494

6.  Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine model.

Authors:  Craig E Grossman; Stephen Pickup; Amy Durham; E Paul Wileyto; Mary E Putt; Theresa M Busch
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

7.  In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma.

Authors:  Martin Ullrich; Ralf Bergmann; Mirko Peitzsch; Marc Cartellieri; Nan Qin; Monika Ehrhart-Bornstein; Norman L Block; Andrew V Schally; Jens Pietzsch; Graeme Eisenhofer; Stefan R Bornstein; Christian G Ziegler
Journal:  Endocrinology       Date:  2014-08-19       Impact factor: 4.736

8.  The utility of micro-CT and MRI in the assessment of longitudinal growth of liver metastases in a preclinical model of colon carcinoma.

Authors:  Prachi Pandit; Samuel M Johnston; Yi Qi; Jennifer Story; Rendon Nelson; G Allan Johnson
Journal:  Acad Radiol       Date:  2013-04       Impact factor: 3.173

9.  Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.

Authors:  L Martiniova; E W Lai; D Thomasson; D O Kiesewetter; J Seidel; M J Merino; R Kvetnansky; K Pacak
Journal:  Endocr Regul       Date:  2009-04

10.  Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature.

Authors:  Lucia Martiniova; Edwin W Lai; Abdel G Elkahloun; Mones Abu-Asab; Andrea Wickremasinghe; Daniel C Solis; Shiromi M Perera; Thanh-Truc Huynh; Irina A Lubensky; Arthur S Tischler; Richard Kvetnansky; Salvatore Alesci; John C Morris; Karel Pacak
Journal:  Clin Exp Metastasis       Date:  2009-01-25       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.